Cargando…

Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy

PURPOSE: This study aimed to explore the key molecular pathways involved in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) and thereby identify hub genes to be potentially used as novel biomarkers using a bioinformatics approach. METHODS: Raw GSE109178 data were collected from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaoxue, Hao, Yuehan, Wu, Jiao, Zhao, Jing, Xiong, Shuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053709/ https://www.ncbi.nlm.nih.gov/pubmed/33883925 http://dx.doi.org/10.2147/PGPM.S301098

Ejemplares similares

Identification of Novel Key Genes and Pathways in Multiple Sclerosis Based on Weighted Gene Coexpression Network Analysis and Long Noncoding RNA-Associated Competing Endogenous RNA Network
por: Hao, Yuehan, et al.
Publicado: (2022)

Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis
por: Wang, Junjie, et al.
Publicado: (2021)

Comprehensive analysis of immune-related biomarkers and pathways in intracerebral hemorrhage using weighted gene co-expression network analysis and competing endogenous ribonucleic acid
por: Hao, Yuehan, et al.
Publicado: (2022)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Identification of hub genes related to Duchenne muscular dystrophy by weighted gene co-expression network analysis
por: Wei, Yanning, et al.
Publicado: (2022)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Biomarkers of Duchenne muscular dystrophy: current findings
por: Szigyarto, Cristina Al-Khalili, et al.
Publicado: (2018)

Cardiac MRI biomarkers for Duchenne muscular dystrophy
por: Magrath, Patrick, et al.
Publicado: (2018)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
por: Ogundele, Michael, et al.
Publicado: (2021)

Weighted Gene Co-expression Network Analysis of Key Biomarkers Associated With Bronchopulmonary Dysplasia
por: Cai, Yao, et al.
Publicado: (2020)

miRNAs as serum biomarkers for Duchenne muscular dystrophy
por: Cacchiarelli, Davide, et al.
Publicado: (2011)

Clinical utility of serum biomarkers in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2016)

Circulating Biomarkers in Muscular Dystrophies: Disease and Therapy Monitoring
por: Koutsoulidou, Andrie, et al.
Publicado: (2020)

MicroRNAs as serum biomarkers in Becker muscular dystrophy
por: Gagliardi, Delia, et al.
Publicado: (2022)

Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne Muscular Dystrophy
por: Galindo, Cristi L., et al.
Publicado: (2015)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Hippo signaling pathway is altered in Duchenne muscular dystrophy
por: Vita, Gian Luca, et al.
Publicado: (2018)

Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
por: Anaya-Segura, Mónica Alejandra, et al.
Publicado: (2015)

Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy
por: Mankodi, Ami, et al.
Publicado: (2017)

Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
por: Grounds, Miranda D., et al.
Publicado: (2020)

Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy
por: Meng, Qi, et al.
Publicado: (2022)

Muscle ultrasound is a sensitive biomarker in oculopharyngeal muscular dystrophy
por: Kroon, Rosemarie H. M. J. M., et al.
Publicado: (2022)

Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions
por: Fortunato, Fernanda, et al.
Publicado: (2023)

Genetic and Clinical Advances of Congenital Muscular Dystrophy
por: Fu, Xiao-Na, et al.
Publicado: (2017)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
por: Chiu, Yen-Hui, et al.
Publicado: (2009)

Identification of Candidate Blood mRNA Biomarkers in Intracerebral Hemorrhage Using Integrated Microarray and Weighted Gene Co-expression Network Analysis
por: Jin, Feng, et al.
Publicado: (2021)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy
por: Parolo, Silvia, et al.
Publicado: (2018)

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2015)

Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
por: Zaharieva, Irina T., et al.
Publicado: (2013)

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2019)

Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy
por: Raz, Vered, et al.
Publicado: (2020)

Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy
por: Strandberg, Kristin, et al.
Publicado: (2020)

Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers
por: Johansson, Camilla, et al.
Publicado: (2023)

Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
por: Mathews, Katherine D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6ekssqe5omtuid911pajp9iap